Axogen, Inc. (AXGN) financial statements (2022 and earlier)

Company profile

Business Address 13631 PROGRESS BLVD.
ALACHUA, FL 32615
State of Incorp. MN
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments84,08691,71999,91790,905103,96699,12899,329
Cash and cash equivalents32,75646,73053,07839,84348,76760,00275,320
Short-term investments51,33044,98946,83951,06255,19939,12624,009
Receivables18,18118,59018,20519,84817,64118,78114,070
Inventory, net of allowances, customer advances and progress billings16,69315,45313,41513,38812,52911,92912,836
Inventory16,69315,45313,41513,38812,52911,92912,836
Prepaid expense1,3592,1192,4943,5173,5971,3712,013
Other undisclosed current assets6,7307,0877,7647,4877,5188,76411,981
Total current assets:127,049134,968141,795135,145145,251139,973140,229
Noncurrent Assets
Finance lease, right-of-use asset42475359647076
Operating lease, right-of-use asset15,19315,58815,27215,44215,61415,9873,138
Property, plant and equipment62,88156,32850,95244,39538,39836,11024,858
Intangible assets, net (including goodwill)2,8592,7012,4602,3282,0541,7971,660
Intangible assets, net (excluding goodwill)2,8592,7012,4602,3282,0541,7971,660
Other noncurrent assets 339     
Total noncurrent assets:80,97575,00368,73762,22456,13053,96429,732
TOTAL ASSETS:208,024209,971210,532197,369201,381193,937169,961
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22,45921,68519,83920,83121,96816,27912,451
Accounts payable5,9236,4286,7219,1574,5973,5073,887
Accrued liabilities6,8636,3615,4805,4343,7783,0912,461
Employee-related liabilities9,6738,8967,6386,24013,5939,6816,103
Deferred revenue14141414141414
Debt9121415172,4991,553
Other undisclosed current liabilities1,8111,6481,7611,413832  
Total current liabilities:24,29323,35921,62822,27322,83118,79214,018
Noncurrent Liabilities
Long-term debt and lease obligation65,61967,50946,08132,14032,02737,9521,651
Long-term debt, excluding current maturities44,82146,23846,08132,14032,02718,976 
Finance lease, liability45   1722
Operating lease, liability20,79421,266   18,9591,629
Liabilities, other than long-term debt5,5623,8223,7762,5212,500121,669
Deferred revenue     69
Other liabilities   2361,660
Derivative instruments and hedges, liabilities5,5623,8223,7762,5192,497  
Other undisclosed noncurrent liabilities  20,34420,73120,87415,46832,863
Total noncurrent liabilities:71,18171,33170,20155,39255,40153,43236,183
Total liabilities:95,47494,69091,82977,66578,23272,22450,201
Stockholders' equity
Stockholders' equity attributable to parent112,550115,281118,703119,704123,149121,713119,760
Common stock417415413408406401400
Additional paid in capital342,765340,212336,495329,603326,390318,949315,518
Accumulated deficit(230,632)(225,346)(218,205)(210,307)(203,647)(197,637)(196,158)
Total stockholders' equity:112,550115,281118,703119,704123,149121,713119,760
TOTAL LIABILITIES AND EQUITY:208,024209,971210,532197,369201,381193,937169,961

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues31,53731,20433,58031,03732,49533,42822,116
Cost of revenue
(Cost of Goods and Services Sold)
(5,428)(5,239)(7,092)(5,172)(5,463)(5,697)(5,605)
Gross profit:26,10925,96526,48825,86527,03227,73116,511
Operating expenses(31,462)(32,654)(33,642)(32,085)(32,406)(28,776)(24,765)
Operating loss:(5,353)(6,689)(7,154)(6,220)(5,374)(1,045)(8,254)
Nonoperating income (expense)67(452)(744)(440)(636)(434)149
Investment income, nonoperating(15)172934(88)28237
Other nonoperating income (expense)(141)(6)(124)(30)(24)6(57)
Interest and debt expense71(417)(565)(444)(1,032)(1)(1)
Net loss:(5,215)(7,558)(8,463)(7,104)(7,042)(1,480)(8,106)
Other undisclosed net income (loss) attributable to parent(71)4175654441,03211
Net loss available to common stockholders, diluted:(5,286)(7,141)(7,898)(6,660)(6,010)(1,479)(8,105)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(5,215)(7,558)(8,463)(7,104)(7,042)(1,480)(8,106)
Comprehensive loss, net of tax, attributable to parent:(5,215)(7,558)(8,463)(7,104)(7,042)(1,480)(8,106)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: